ALDEYRA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.93 USD | -0.25% |
|
+1.81% | +11.97% |
| Apr. 25 | Transcript : Aldeyra Therapeutics, Inc. - Special Call | |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Chart calendar Aldeyra Therapeutics, Inc.
4d0a88b673e1.a7-aXpC_tqT-W2YPuibjVwqSlYVvO_x3qB63JCWuDHA.H8nZCPrRwc2bOEtky1fRCEPA5fU-VYYEmWr7F3DtVAIF9PAno-nR1bI-FQ~c2107759a7539283216bf99f0a549b0b
Past events on Aldeyra Therapeutics, Inc.
| 2024-04-25 09:00 am | Research & Development Day |
| 2024-03-28 08:00 am | Business Update Call |
| 2024-02-13 04:00 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2023-12-19 08:00 am | ADX?629 Phase 2 Clinical Trial Call |
| 2023-11-28 08:00 am | Business Update Call |
| 2023-07-10 | SVB Securities Therapeutics Forum |
| 2023-06-30 08:00 am | Annual General Meeting |
| 2023-06-29 08:00 am | ADX?2191 Phase 2 Clinical Trial Results Call |
| 2023-06-27 08:00 am | ADX?629 Phase 2 clinical Trial Results Call |
| 2023-06-15 08:00 am | INVIGORATE?2 Phase 3 Trial Results Call |
| 2023-06-09 09:30 am | Jefferies Global Healthcare Conference |
| 2023-05-04 07:00 am | Q1 2023 Earnings Release |
| 2023-03-09 08:00 am | Q4 2022 Earnings Call |
| 2023-03-09 07:00 am | Q4 2022 Earnings Release |
| 2023-02-16 10:00 am | SVB Securities Global Biopharma Conference |
| 2022-11-10 08:00 am | Q3 2022 Earnings Call |
| 2022-11-10 07:00 am | Q3 2022 Earnings Release |
| 2022-10-25 | American Academy of Optometry Meeting |
| 2022-10-24 | American Academy of Optometry Meeting |
| 2022-10-06 08:00 am | ADX-2191 Phase 3 GUARD Trial Results Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,43 - | 28,4 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -56,0 -56,5 0.92% | -62,4 -64,3 2.94% | 0,00 -41,0 - | -38,4 |
|
EBIT Million USD | Released Forecast Spread | -63,1 -69,2 8.79% | -36,4 -35,4 -2.95% | -56,2 -57,1 1.52% | -62,7 -67,7 7.42% | -42,8 -46,5 7.96% | -23,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -62,1 -67,7 8.28% | -38,0 -37,0 -2.9% | -57,8 -58,5 1.32% | -62,0 -68,6 9.64% | -37,5 -42,7 12.06% | -16,0 |
|
Net income Million USD | Released Forecast Spread | -60,8 -66,4 8.45% | -37,6 -37,0 -1.6% | -57,8 -58,7 1.5% | -62,0 -68,5 9.39% | -37,5 -40,9 8.26% | -1,58 |
|
EPS USD | Released Forecast Spread | -2,24 -2,42 7.53% | -1,11 -1,09 -1.72% | -1,07 -1,09 1.95% | -1,06 -1,16 8.88% | -0,64 -0,70 7.91% | -0,05 |
| Announcement Date | 12/03/20 | 11/03/21 | 17/03/22 | 09/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,43 - | 1,20 | 0,00 | 0,00 | 18,8 |
|
EBITDA Million USD | Released Forecast Spread | -4,50 | -7,44 | -8,83 | -10,5 | -11,7 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -15,4 -16,3 5.35% | -16,5 -16,5 0.11% | -17,7 -18,1 1.93% | -14,8 -20,8 29.03% | -13,7 -19,3 28.86% | -16,8 -16,8 0.14% | -10,3 -17,9 42.21% | -9,55 -14,6 34.7% | -6,10 -9,80 37.78% | -8,10 | -9,07 | -10,5 | -11,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,8 -16,6 5.22% | -16,8 -16,9 0.57% | -17,8 -18,3 2.98% | -14,6 -20,9 30.53% | -12,9 -19,5 33.85% | -15,6 -17,0 8.01% | -8,99 -17,5 48.65% | -8,19 -13,9 40.89% | -4,75 -9,90 51.98% | -7,08 | -7,94 | -9,26 | -10,4 |
|
Net income Million USD | Released Forecast Spread | -15,8 -16,7 5.85% | -16,8 -18,9 11.31% | -17,8 -18,5 4.01% | -14,6 -20,8 29.89% | -12,9 -19,3 33.22% | -15,6 -17,0 8.24% | -8,99 -17,9 49.8% | -8,19 -14,0 41.42% | -4,75 -8,15 41.66% | -5,80 | -7,96 | -9,64 | 27,7 |
|
EPS USD | Released Forecast Spread | -0,27 -0,29 5.97% | -0,29 -0,33 10.96% | -0,30 -0,32 5.26% | -0,25 -0,35 28.57% | -0,22 -0,32 31.61% | -0,27 -0,29 6.36% | -0,15 -0,30 50.55% | -0,14 -0,24 40.85% | -0,08 -0,14 42.17% | -0,10 | -0,13 | -0,16 | 0,43 |
| Announcement Date | 17/03/22 | 05/05/22 | 05/08/22 | 10/11/22 | 09/03/23 | 04/05/23 | 03/08/23 | 03/11/23 | 07/03/24 | - | - | - | - |
More events
Past sector events for Aldeyra Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALDX Stock
- Calendar Aldeyra Therapeutics, Inc.
